Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
✉ Email this page to a colleague
OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-07-25 |
Court | District Court, D. New Jersey | Date Terminated | 2017-09-29 |
Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
Jury Demand | Referred To | Karen M. Williams | |
Patents | 8,017,615; 8,580,796; 8,642,760; 8,759,350 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED
Details for OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-05-04 | 246 | Torrent, by contrast, Otsuka asserts U.S. Patent Nos. 8,017,615 and 8,580,796. (See Second Am. Compl. in… 1 The patents asserted by Otsuka in this infringement action specifically include U.S. Patent Nos. 8,642,760… 8,642,760 (“the ’760 patent”) and 8,759,350 (hereinafter, “the ’350 patent”). (See generally Third …collectively, “Torrent”) infringe the various patents covering Otsuka’s aripiprazole product, Abilify…which also involves Torrent) in terms of the patents asserted by Otsuka. More specifically, in this | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |